This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cramer's 'Mad Money' Recap: A Portfolio From Your Morning Routine

Rounding out the portfolio is Verizon (VZ), a company with no European exposure and a juicy 4.5% dividend yield on top of consistent, reliable earnings.

Predicting Performance

Can a company's first-half performance predict how it'll do in the second half of the year? Cramer put it up to a vote as he nominated five first-half performers and told viewers to choose their favorite by voting on Twitter @JimCramer using #stockderby.

Arena Pharmaceuticals (ARNA) is the first "home run hitter" nominee, up 225% so far this year on FDA approval for its new obesity drug. While the drug is not slated to be on the market until late-2012, Cramer said the market opportunity for Arena remains huge.

Next up is Onyx Pharmaceuticals (ONXX), a stock up 76% for the year on takeover chatter as well as the latest FDA approval anticipations.

Also making the list, the first airline every considered on Mad Money, US Airways (LCC). Cramer said while US Airways won't be getting his vote, the stock is up 75% for the year and with fuel prices plummeting and the disarray at American Airlines continuing, the company is worthy of a mention.

Fourth is Mellanox Technologies (MLNX), the Israeli technology firm helping to make your data move faster. This company has a track record of UPOD, or under-promising and over-delivering, said Cramer, and it's stock is up 69% for the year.

Finally, Pharmacyclics (PCYC), another biotech name, completes the list. Shares of Pharmacyclics are up 97% for the year, but Cramer noted that the company has done little since its inception in 1996 and 10% of its shares are currently sold short.

Cramer told viewers to do their homework, then hop on Twitter to let him know which company gets their vote for the best performance in the second half of the year.

Lightning Round

Here's what Cramer had to say about callers' stocks during the "Lightning Round":

Velti (VELT): "No, that stock is not to be owned. I want nothing to do with mobile advertising."

Talisman Energy (TLM): "That's a second-rate oil company in an environment where the first-rate ones are going down."

2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,959.44 +154.64 0.87%
S&P 500 2,078.54 +7.89 0.38%
NASDAQ 4,781.4240 +16.0440 0.34%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs